False-positive results of a rapid K39-based strip test and Chagas disease

Gazzinelli, 2004, Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites, Immunol Rev, 201, 9, 10.1111/j.0105-2896.2004.00174.x Berman, 1997, Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years, Clin Infect Dis, 24, 684, 10.1093/clind/24.4.684 Schwartz, 2006, New world cutaneous leishmaniasis in travellers, Lancet Infect Dis, 6, 342, 10.1016/S1473-3099(06)70492-3 Alvar, 1997, Leishmania and human immunodeficiency virus coinfection: the first 10 years, Clin Microbiol Rev, 10, 298, 10.1128/CMR.10.2.298 Sundar, 2002, Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit, Clin Infect Dis, 35, 581, 10.1086/342057 Jha, 1999, Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis, N Engl J Med, 341, 1795, 10.1056/NEJM199912093412403 Ferreira, 2006, Methylene blue vital staining for Trypanosoma cruzi trypomastigotes and epimastigotes, Rev Inst Med Trop Sao Paulo, 48, 347, 10.1590/S0036-46652006000600009 Braz, 2001, Trypanosoma cruzi parasitemia observed in immunocompromised patients: the importance of the artificial xenodiagnosis, Rev Inst Med Trop Sao Paulo, 43, 113, 10.1590/S0036-46652001000200012 Amato Neto, 2005, Observations on the use of TESA blot for the serological diagnosis of Chagas’ disease, Rev Soc Bras Med Trop, 38, 534, 10.1590/S0037-86822005000600019 Tuon, 2007, Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids—first report, Int J Dermatol, 46, 628, 10.1111/j.1365-4632.2006.03096.x Matsumoto, 2002, Trypanosoma cruzi: isolation of an immunodominant peptide of TESA (trypomastigote excreted-secreted antigens) by gene cloning, Diagn Microbiol Infect Dis, 42, 187, 10.1016/S0732-8893(01)00348-0 Umezawa, 2001, Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas’ disease, Diagn Microbiol Infect Dis, 39, 169, 10.1016/S0732-8893(01)00216-4 Ferreira, 2001, Enzyme-linked immunosorbent assay for serological diagnosis of Chagas’ disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides, J Clin Microbiol, 39, 4390, 10.1128/JCM.39.12.4390-4395.2001 Santos Coelho, 2007, A multianalyte Dot-ELISA for simultaneous detection of malaria, Chagas disease, and syphilis-specific IgG antibodies, Diagn Microbiol Infect Dis, 58, 223, 10.1016/j.diagmicrobio.2006.12.011 Berrizbeitia, 2006, Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas’ disease, J Clin Microbiol, 44, 291, 10.1128/JCM.44.2.291-296.2006 Burns, 1993, Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis, Proc Natl Acad Sci U S A, 90, 775, 10.1073/pnas.90.2.775